Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
289 participants
OBSERVATIONAL
2007-11-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Stroke can be responsible of central apneas, therefore the differential diagnosis between central apneas and pure OSA after stroke is sometimes difficult. The misidentification of OSA can explain the poor tolerance of CPAP treatment by these patients. The purpose of the present study is to investigate the association between pre-stroke OSA syndrome OSA diagnosed on specific scales and confirmed by polygraphic studies and stroke occurrence.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Consequences of Obstructive Sleep Apnea Syndrome (OSAS) After Ischemic Subtentorial Stroke.
NCT01561677
Ischaemic Stroke and Sleep Apnea in Northern Part of Finland
NCT01861275
Cerebrovascular Reactivity in Obstructive Sleep Apnea (OSA) Subjects
NCT01133717
Continuous Positive Airway Pressure on Acute Stroke and Obstructive Sleep Apnea
NCT04458779
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
NCT06150352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
• Secondary Objective :
Evaluate the relation between obstructive sleep apnea and:
* stroke mechanisms
* stroke prognosis
* post-stroke tolerance to CPAP treatment.
* Study design :
Prospective case-control study
• Inclusion criteria :
Patients (150):
Fist ischaemic hemispheric stroke or TIA Age: 50 to 90 French native speaker Able to answer the questions
Controls (600):
Age: 50 to 90 French native speaker Able to answer the questions
• Exclusion criteria : Patients Haemorrhagic stroke Stroke of the brainstem Past medical history of ischaemic stroke Dementia Confusion Unable to give his informed consent
Controls:
Past medical history of ischaemic stroke Dementia Confusion Unable to give his informed consent
• Study plan: Cases will be recruited in the stroke unit of the Pr Orgogozo at the Bordeaux University hospital. After verification of inclusion and exclusion criteria Berlin scale will be measured. A polygraphic study will be performed to patients with a Berlin scale \> 2. Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional outcome).
Controls will be recruited among sex and age matched patients hospitalized at the Bordeaux-University hospital for investigation of non-vascular disorder. After verification of inclusion and exclusion criteria Berlin scale will be measured. A polygraphic study will be performed to subjects with a Berlin scale \> 2. Controls will be evaluated at 3 months using a phone interview
• Number of subjects : 150 cases and 600 controls
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
case
Fist ischaemic hemispheric stroke or TIA
polygraphic study
Berlin scale will be measured. A polygraphic study will be performed to subjects with a Berlin scale \> 2.
Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional outcome).
Controls will be evaluated at 3 months using a phone interview
control
No ischaemic hemispheric stroke or TIA
polygraphic study
Berlin scale will be measured. A polygraphic study will be performed to subjects with a Berlin scale \> 2.
Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional outcome).
Controls will be evaluated at 3 months using a phone interview
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
polygraphic study
Berlin scale will be measured. A polygraphic study will be performed to subjects with a Berlin scale \> 2.
Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional outcome).
Controls will be evaluated at 3 months using a phone interview
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 50 to 90
* French native speaker
* Able to answer the questions
* Age: 50 to 90
* French native speaker
* Able to answer the questions
Exclusion Criteria
* Stroke of the brainstem
* Past medical history of ischaemic stroke
* Dementia
* Confusion
* Unable to give his informed consent
* Past medical history of ischaemic stroke
* Dementia
* Confusion
* Unable to give his informed consent
50 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Marc ORGOGOZO, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Groupe Hospitalier Pellegrin - Place Amélie Raba Léon
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-A00382-51
Identifier Type: -
Identifier Source: secondary_id
CHUBX2006/10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.